Interactions have not been studied.

They need to know if you have any of these conditions:
-Heart disease
-Infection, such as chickenpox, cold sores, herpes, hepatitis B
-Lung or breathing disease
-An unusual or allergic reaction to daratumumab, hyaluronidase, other medications, foods, dyes, or preservatives
-Pregnant or trying to get pregnant
-Breast-feeding

Your condition will be monitored carefully while you are receiving this medication.
This medication can cause serious allergic reactions. To reduce your risk, your care team may give you other medication to take before receiving this one. Be sure to follow the directions from your care team.
This medication can affect the results of blood tests to match your blood type. These changes can last for up to 6 months after the final dose. Your care team will do blood tests to match your blood type before you start treatment. Tell all of your care team that you are being treated with this medication before receiving a blood transfusion.
This medication can affect the results of some tests used to determine treatment response; extra tests may be needed to evaluate response.
Talk to your care team if you wish to become pregnant or think you are pregnant. This medication can cause serious birth defects if taken during pregnancy and for 3 months after the last dose. A reliable form of contraception is recommended while taking this medication and for 3 months after the last dose. Talk to your care team about effective forms of contraception.
Do not breast-feed while taking this medication.

This medication is given in a hospital or clinic. It will not be stored at home.